The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price decrease of -40.51%. However, over the past six months, we’ve seen a stronger performance of -13.82%. The price of RLAY leaped by -3.53% over the last 30 days. And in the last five days, it has fallen by -10.15%.
The stock market performance of Relay Therapeutics Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $12.14 on 01/08/24, while the lowest price during the same time frame was $5.70, recorded on 04/24/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of RLAY Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Relay Therapeutics Inc’s current trading price is -46.05% away from its 52-week high, while its distance from the 52-week low is 14.91%. The stock’s price range for this period has been between $5.70 and $12.14. The Healthcare sector company’s shares saw a trading volume of about 1.67 million for the day, which was lower than the average daily volume of 1.88 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Relay Therapeutics Inc (RLAY) has experienced a quarterly rise of 1.24% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.06B and boasts a workforce of 323 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 7.26, with a change in price of +0.04. Similarly, Relay Therapeutics Inc recorded 1,725,394 in trading volume during the last 100 days, posting a change of +0.61%.
RLAY’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for RLAY stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.07.
RLAY Stock Stochastic Average
As of today, the raw stochastic average of Relay Therapeutics Inc over the past 50 days is 9.74%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 9.74%. Additionally, the Stochastic %K and %D values for the company were 20.13% and 24.17%, respectively, over the past 20 days.
